It is not intended for human or animal consumption, medical use, or diagnostic purposes
Heart Health Protection When people who are overweight use GLP-1 medications, they tend to experience broad cardiovascular and metabolic health improvements, depending on the medication
Another study demonstrated a remarkable 42% reduction in glucose area under the curve and a 40% reduction in insulin area under the curve compared to placebo
Medicare will cover GLP-1s for a BMI of 35 or more, or a BMI of 27 or more with some qualifying conditions: The prescription must be for weight reduction and weight maintenance in combination with lifestyle modification (structured nutrition and physical activity)
In trials focused on people with type 2 diabetes, a population already at elevated heart risk, GLP-1s consistently reduced serious cardiovascular events by 1226% depending on the drug and population, with strong results for stroke prevention
134979-01-4, CH2COOH-PEG2-NH2.HCl References: [1] Gribble FM, Reimann F
